HomeOpen Access NewsDrug Development

Drug Development

Subscribe to Updates

Cambridge develops smart artificial cartilage for targeted arthritis relief

Pharma
Cambridge scientists develop artificial cartilage that delivers anti-inflammatory drugs directly to inflamed joints, promising more effective, targeted arthritis relief.

Liverpool University to lead £1.3m initiative to combat antimicrobial resistance

Health & Social Care
In an aim towards battling the global threat of antimicrobial resistance (AMR), the University of Liverpool has been granted £1.3 million to lead the UK Government’s Fleming Fund Fellowship Programme.

No more migraines? New daily pill approved in England could half migraine frequency

Health & Social Care
A new daily pill that can effectively reduce the frequency of migraine attacks has been approved for use by the National Institute for Health and Care Excellence (NICE).

Scientists discover cost-effective method to produce key drug molecules

Pharma
Scientists at Scripps Research have revealed a new approach to synthesising crucial molecules used in drug development.

Ketamine’s potential to help social impairments in depression

Mental Health
Loneliness and isolation have become a prevalent issue in today's society, with depression in particular affecting many lives.

New machine-learning model identifies drug interactions for safer prescribing

Technology
Researchers have unveiled a new machine-learning approach to predict drug-accurate interactions.

Breakthrough in depression treatment: AI predicts antidepressant response within a week

Mental Health
Researchers from Amsterdam UNC and Radboundumc have revealed a method to predict the effectiveness of antidepressants within a week of treatment This advancement powered by...

Antisense therapies: A new approach to tackling challenging targets in areas of high unmet medical need

Health & Social Care
Alexander Gebauer, the Chief Executive Officer at Secarna Pharmaceuticals GmbH & Co. KG looks at a new approach to solve unmet medical needs with...

Secarna: Next generation antisense therapeutics

Pharma
Leading independent European antisense drug discovery company, Secarna, aims to bring novel and effective antisense therapeutic options to an increasing number of patients. CEO Alexander Gebauer tells us how.

Breast cancer drug made accessible to 289,000 women in England

Cancer Research
Anastrozole is to be made accessible to postmenopausal women who have a family history of breast cancer to help prevent the disease 

Less frequent, equally effective, weekly insulin injections: The future of diabetes treatment

Diseases & Conditions
Research conducted by the University of Surrey suggests that insulin icodec, a weekly basal injection, may be just as effective when treating type 1 diabetes compared to daily basal insulin treatments.

Blocking brain cell death shows promise in new Alzheimer’s treatment

Diseases & Conditions
Blocking the MEG3 molecule holds promise as a potential Alzheimer's treatment by delaying brain cell death.

Finger sweat test detects antipsychotic drugs in patients

Pharma
Innovative finger sweat test provides patients with a more comfortable and non-invasive way to monitor antipsychotic drug levels.

Innovative paediatric research: Investigating the 3D printing of medication

Pharma
The NIH has awarded a grant of $3 million in the hope of supporting the 3D printing of medication tailored towards helping paediatric patients.

£210 million allocated by UK government to tackle antimicrobial resistance (AMR)

Health & Social Care
In a groundbreaking move, the UK government has committed up to £210 million from its aid budget to tackle antimicrobial resistance (AMR).

How can connected drug delivery devices help patients adhere to their therapies?

Pharma
Poor adherence to drug therapies can lead to medication waste and poor patient outcomes. Tim Wooller shares some of the reasons behind poor adherence to medication and how connected drug delivery devices can help.

Researchers unravel HIV drug resistance mechanisms

Diseases & Conditions
The National Institutes of Health and Salk Institute researchers have made strides in understanding the molecular mechanisms behind HIV drug resistance mechanisms.
1234...16Page 3 of 16

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders

Visit Article Archive
Open Access Government

Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.

Follow Us

Resources

Quick Links

Legal & Marketing

As a Crossref Sponsored Member we are able to connect your content with a global network of online scholarly research, currently over 20,000 other organizational members from 160 countries. Crossref drive metadata exchange and support nearly 2 billion monthly API queries, facilitating global research communication.

© Adjacent Digital Politics Ltd